{"id":5767,"date":"2022-09-07T02:02:44","date_gmt":"2022-09-07T02:02:44","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=5767"},"modified":"2023-08-29T17:55:30","modified_gmt":"2023-08-29T17:55:30","slug":"argenica-therapeutics-ethics-approval-phase-1-clinical-trial-stroke-drug-arg-007","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=5767","title":{"rendered":"Argenica Therapeutics \u83b7\u5f97\u4e2d\u98ce\u836f\u7269 ARG-007 1 \u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u4f26\u7406\u6279\u51c6"},"content":{"rendered":"

\u603b\u90e8\u4f4d\u4e8e\u73c0\u65af\u7684\u751f\u7269\u6280\u672f\u516c\u53f8 Argenica Therapeutics (ASX: AGN) \u5df2\u83b7\u5f97\u4f26\u7406\u6279\u51c6\uff0c\u53ef\u4ee5\u5728\u5065\u5eb7\u53c2\u4e0e\u8005\u4e2d\u5f00\u59cb\u5148\u5bfc\u836f\u7269 ARG-007 \u7684\u5173\u952e 1 \u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002<\/p>\n

ARG-007 \u6b63\u5728\u88ab\u5f00\u53d1\u4e3a\u4e00\u79cd\u65b0\u7684\u6cbb\u7597\u65b9\u6cd5\uff0c\u53ef\u51cf\u5c11\u4e2d\u98ce\u540e\u7684\u8111\u7ec4\u7ec7\u6b7b\u4ea1\uff0c\u5e76\u6709\u53ef\u80fd\u5728\u4e2d\u98ce\u53d1\u751f\u540e\u4fc3\u8fdb\u6062\u590d\u3002<\/p>\n

\u5728\u5411\u6fb3\u5927\u5229\u4e9a\u7814\u7a76\u4f26\u7406\u516c\u53f8 Bellberry \u63d0\u51fa\u7533\u8bf7\u540e\uff0c\u8be5\u8bd5\u9a8c\u83b7\u5f97\u4e86\u6279\u51c6\uff0c\u8be5\u516c\u53f8\u7684\u5b58\u5728\u662f\u4e3a\u4e86\u4fdd\u62a4\u4eba\u7c7b\u7814\u7a76\u9879\u76ee\u53c2\u4e0e\u8005\u7684\u798f\u5229\uff0c\u5e76\u786e\u4fdd\u8be5\u7814\u7a76\u7684\u8d28\u91cf\u3001\u6548\u7387\u548c\u6709\u6548\u6027\u3002<\/p>\n

Argenica \u7684\u8bd5\u9a8c\u5c06\u7531\u5f53\u5730\u516c\u53f8 Linear Clinical Research \u5728\u73c0\u65af\u7684\u4e13\u95e8\u8bbe\u65bd\u8fdb\u884c\u3002<\/p>\n

Linear \u5df2\u5f00\u59cb\u62db\u52df\u591a\u8fbe 32 \u540d\u5065\u5eb7\u5fd7\u613f\u8005\uff0c\u7b2c\u4e00\u6279\u60a3\u8005\u7684\u7ed9\u836f\u8ba1\u5212\u4e8e 10 \u6708\u8fdb\u884c\u3002<\/p>\n

\u8bd5\u9a8c\u7ed3\u6784<\/h2>\n

1 \u671f\u8bd5\u9a8c\u5c06\u7531\u56db\u7ec4\u516b\u540d\u53c2\u4e0e\u8005\u7ec4\u6210\uff0c\u6bcf\u7ec4\u53c2\u4e0e\u8005\u5c06\u88ab\u968f\u673a\u5206\u914d\u63a5\u53d7 ARG-007 \u6216\u5728\u7b2c\u4e00\u5929\u4f5c\u4e3a\u5355\u6b21\u9759\u8109\u5185\u7ed9\u836f\u7684\u5339\u914d\u5b89\u6170\u5242\u3002<\/p>\n

\u53c2\u4e0e\u8005\u5c06\u88ab\u7eb3\u5165\u987a\u5e8f\u7ec4\uff0c\u7b2c\u4e00\u7ec4\u63a5\u53d7\u6700\u4f4e\u5242\u91cf\u7684 ARG-007 \u6216\u5b89\u6170\u5242\uff0c\u800c\u5176\u4f59\u7ec4\u5c06\u63a5\u53d7\u7a0d\u9ad8\u7684\u5242\u91cf\u3002<\/p>\n

\u5728\u589e\u52a0\u540e\u7eed\u7ec4\u7684\u5242\u91cf\u4e4b\u524d\uff0c\u59d4\u5458\u4f1a\u5c06\u5ba1\u67e5\u7b2c\u4e00\u7ec4\u7684\u5b89\u5168\u6027\u6570\u636e\u3002<\/p>\n

\u6bcf\u7ec4\u5c06\u5305\u62ec\u4e24\u540d\u54e8\u5175\u53d7\u8bd5\u8005\uff0c\u5176\u4e2d\u4e00\u540d\u5c06\u5206\u914d\u7ed9 ARG-007\uff0c\u53e6\u4e00\u540d\u5206\u914d\u7ed9\u5b89\u6170\u5242\u3002<\/p>\n

\u54e8\u5175\u53d7\u8bd5\u8005\u5c06\u5728\u7ec4\u4e2d\u5269\u4f59\u53c2\u4e0e\u8005\u4e4b\u524d\u4e00\u5929\u7ed9\u836f\u5e76\u76d1\u6d4b 24 \u5c0f\u65f6\u3002<\/p>\n

\u5982\u679c\u8ba4\u4e3a\u8be5\u5242\u91cf\u5728\u6b64\u671f\u95f4\u540e\u8010\u53d7\u6027\u826f\u597d\uff0c\u5219\u6bcf\u7ec4\u4e2d\u5269\u4f59\u7684\u516d\u540d\u53c2\u4e0e\u8005\u5c06\u88ab\u7ed9\u836f\u3002<\/p>\n

\u5c06\u8bb0\u5f55\u5b89\u5168\u6027\u3001\u8010\u53d7\u6027\u3001\u836f\u4ee3\u52a8\u529b\u5b66\uff08\u5e38\u89c4\u8840\u6837\uff09\u548c\u514d\u75ab\u53cd\u5e94\u8bc4\u4f30\u3002<\/p>\n

\u4e2d\u98ce\u7edf\u8ba1<\/h2>\n

\u636e\u7edf\u8ba1\uff0c\u4e16\u754c\u4e0a\u6bcf19\u5206\u949f\u5c31\u6709\u4e00\u4eba\u4e2d\u98ce\u3002<\/p>\n

2019 \u5e74\uff0c\u8fd9\u76f8\u5f53\u4e8e\u5168\u7403 1300 \u4e07\u4eba\u3002<\/p>\n

\u5728\u4e2d\u98ce\u671f\u95f4\uff0c\u7531\u8840\u7ba1\u963b\u585e\u5f15\u8d77\u7684\u7f3a\u6c27\uff08\u7f3a\u6c27\uff09\u6bcf\u5206\u949f\u4f1a\u6740\u6b7b 190 \u4e07\u4e2a\u8111\u7ec6\u80de\u3002<\/p>\n

\u4e2d\u98ce\u60a3\u8005\u53ef\u7528\u7684\u533b\u7597\u5e72\u9884\u63aa\u65bd\u6709\u9650\uff0c\u4e3b\u8981\u96c6\u4e2d\u5728\u5316\u5b66\u6216\u673a\u68b0\u53bb\u9664\u51dd\u5757\uff0c\u4f7f\u7528\u6297\u51dd\u5242\u548c\u6eb6\u6813\u836f\u7269\u5206\u89e3\u5bfc\u81f4\u963b\u585e\u7684\u51dd\u5757\u3002<\/p>\n

\u5927\u7ea6 35% \u7684\u6025\u6027\u5352\u4e2d\u60a3\u8005\u5728\u5173\u952e\u7684 4.5 \u5c0f\u65f6\u7a97\u53e3\u5185\u5230\u8fbe\u533b\u9662\u63a5\u53d7\u6cbb\u7597\u3002<\/p>\n

\u672a\u80fd\u8fbe\u5230\u8fd9\u4e2a\u72ed\u7a84\u7684\u65f6\u95f4\u8303\u56f4\u4e0e\u4e0d\u826f\u7684\u4e34\u5e8a\u7ed3\u679c\u548c\u957f\u671f\u7684\u5065\u5eb7\u95ee\u9898\u6709\u5173\u3002<\/p>\n

\u76ee\u524d\u5e02\u573a\u4e0a\u6ca1\u6709\u53ef\u4ee5\u51cf\u7f13\u5927\u8111\u7f3a\u6c27\u5f71\u54cd\u7684\u795e\u7ecf\u4fdd\u62a4\u836f\u7269\u3002<\/p>\n

ARG-007 \u5f00\u53d1<\/h2>\n

ARG-007 \u5316\u5408\u7269\u7531\u897f\u6fb3\u5927\u5229\u4e9a\u5927\u5b66\u548c Perron \u795e\u7ecf\u5b66\u548c\u8f6c\u5316\u79d1\u5b66\u7814\u7a76\u6240\u7684\u7814\u7a76\u4eba\u5458\u5f00\u53d1\uff0c\u5e76\u5728\u4e2d\u98ce\u7684\u4e34\u5e8a\u524d\u6a21\u578b\u4e2d\u663e\u793a\u51fa\u6539\u5584\u7684\u7ed3\u679c\u3002<\/p>\n

\u8fd9\u4e9b\u521d\u6b65\u7ed3\u679c\u4fc3\u4f7f Argenica \u5728 2019 \u5e74\u672b\u7eb3\u5165\u8be5\u836f\u7269\u7684\u5f00\u53d1\u548c\u5546\u4e1a\u5316\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"

\u603b\u90e8\u4f4d\u4e8e\u73c0\u65af\u7684\u751f\u7269\u6280\u672f\u516c\u53f8 Argenica Therapeutics (ASX: AGN) \u5df2\u83b7\u5f97\u4f26\u7406\u6279\u51c6\uff0c\u53ef\u4ee5\u5728\u5065\u5eb7\u53c2\u4e0e\u8005\u4e2d\u5f00\u59cb\u5148\u5bfc\u836f\u7269 ARG-007 \u7684\u5173\u952e 1 \u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002 ARG-007 \u6b63\u5728\u88ab\u5f00\u53d1\u4e3a\u4e00\u79cd\u65b0\u7684\u6cbb\u7597\u65b9\u6cd5\uff0c\u53ef\u51cf\u5c11\u4e2d\u98ce\u540e\u7684\u8111\u7ec4\u7ec7\u6b7b\u4ea1\uff0c\u5e76\u6709\u53ef\u80fd\u5728\u4e2d\u98ce\u53d1\u751f\u540e\u4fc3\u8fdb\u6062\u590d\u3002 \u5728\u5411\u6fb3\u5927\u5229\u4e9a\u7814\u7a76\u4f26\u7406\u516c\u53f8 Bellberry \u63d0\u51fa\u7533\u8bf7\u540e\uff0c\u8be5\u8bd5\u9a8c\u83b7\u5f97\u4e86\u6279\u51c6\uff0c\u8be5\u516c\u53f8\u7684\u5b58\u5728\u662f\u4e3a\u4e86\u4fdd\u62a4\u4eba\u7c7b\u7814\u7a76\u9879\u76ee\u53c2\u4e0e\u8005\u7684\u798f\u5229\uff0c\u5e76\u786e\u4fdd\u8be5\u7814\u7a76\u7684\u8d28\u91cf\u3001\u6548\u7387\u548c\u6709\u6548\u6027\u3002 Argenica \u7684\u8bd5\u9a8c\u5c06\u7531\u5f53\u5730\u516c\u53f8 Linear Clinical Research \u5728\u73c0\u65af\u7684\u4e13\u95e8\u8bbe\u65bd\u8fdb\u884c\u3002 Linear \u5df2\u5f00\u59cb\u62db\u52df\u591a\u8fbe 32 \u540d\u5065\u5eb7\u5fd7\u613f\u8005\uff0c\u7b2c\u4e00\u6279\u60a3\u8005\u7684\u7ed9\u836f\u8ba1\u5212\u4e8e 10 \u6708\u8fdb\u884c\u3002 \u8bd5\u9a8c\u7ed3\u6784 1 \u671f\u8bd5\u9a8c\u5c06\u7531\u56db\u7ec4\u516b\u540d\u53c2\u4e0e\u8005\u7ec4\u6210\uff0c\u6bcf\u7ec4\u53c2\u4e0e\u8005\u5c06\u88ab\u968f\u673a\u5206\u914d\u63a5\u53d7 ARG-007 \u6216\u5728\u7b2c\u4e00\u5929\u4f5c\u4e3a\u5355\u6b21\u9759\u8109\u5185\u7ed9\u836f\u7684\u5339\u914d\u5b89\u6170\u5242\u3002 \u53c2\u4e0e\u8005\u5c06\u88ab\u7eb3\u5165\u987a\u5e8f\u7ec4\uff0c\u7b2c\u4e00\u7ec4\u63a5\u53d7\u6700\u4f4e\u5242\u91cf\u7684 ARG-007 \u6216\u5b89\u6170\u5242\uff0c\u800c\u5176\u4f59\u7ec4\u5c06\u63a5\u53d7\u7a0d\u9ad8\u7684\u5242\u91cf\u3002 \u5728\u589e\u52a0\u540e\u7eed\u7ec4\u7684\u5242\u91cf\u4e4b\u524d\uff0c\u59d4\u5458\u4f1a\u5c06\u5ba1\u67e5\u7b2c\u4e00\u7ec4\u7684\u5b89\u5168\u6027\u6570\u636e\u3002 \u6bcf\u7ec4\u5c06\u5305\u62ec\u4e24\u540d\u54e8\u5175\u53d7\u8bd5\u8005\uff0c\u5176\u4e2d\u4e00\u540d\u5c06\u5206\u914d\u7ed9 ARG-007\uff0c\u53e6\u4e00\u540d\u5206\u914d\u7ed9\u5b89\u6170\u5242\u3002 \u54e8\u5175\u53d7\u8bd5\u8005\u5c06\u5728\u7ec4\u4e2d\u5269\u4f59\u53c2\u4e0e\u8005\u4e4b\u524d\u4e00\u5929\u7ed9\u836f\u5e76\u76d1\u6d4b 24 \u5c0f\u65f6\u3002 \u5982\u679c\u8ba4\u4e3a\u8be5\u5242\u91cf\u5728\u6b64\u671f\u95f4\u540e\u8010\u53d7\u6027\u826f\u597d\uff0c\u5219\u6bcf\u7ec4\u4e2d\u5269\u4f59\u7684\u516d\u540d\u53c2\u4e0e\u8005\u5c06\u88ab\u7ed9\u836f\u3002 \u5c06\u8bb0\u5f55\u5b89\u5168\u6027\u3001\u8010\u53d7\u6027\u3001\u836f\u4ee3\u52a8\u529b\u5b66\uff08\u5e38\u89c4\u8840\u6837\uff09\u548c\u514d\u75ab\u53cd\u5e94\u8bc4\u4f30\u3002 \u4e2d\u98ce\u7edf\u8ba1 \u636e\u7edf\u8ba1\uff0c\u4e16\u754c\u4e0a\u6bcf19\u5206\u949f\u5c31\u6709\u4e00\u4eba\u4e2d\u98ce\u3002 2019 \u5e74\uff0c\u8fd9\u76f8\u5f53\u4e8e\u5168\u7403 1300 \u4e07\u4eba\u3002 \u5728\u4e2d\u98ce\u671f\u95f4\uff0c\u7531\u8840\u7ba1\u963b\u585e\u5f15\u8d77\u7684\u7f3a\u6c27\uff08\u7f3a\u6c27\uff09\u6bcf\u5206\u949f\u4f1a\u6740\u6b7b 190 \u4e07\u4e2a\u8111\u7ec6\u80de\u3002 \u4e2d\u98ce\u60a3\u8005\u53ef\u7528\u7684\u533b\u7597\u5e72\u9884\u63aa\u65bd\u6709\u9650\uff0c\u4e3b\u8981\u96c6\u4e2d\u5728\u5316\u5b66\u6216\u673a\u68b0\u53bb\u9664\u51dd\u5757\uff0c\u4f7f\u7528\u6297\u51dd\u5242\u548c\u6eb6\u6813\u836f\u7269\u5206\u89e3\u5bfc\u81f4\u963b\u585e\u7684\u51dd\u5757\u3002 \u5927\u7ea6 35%… Continue reading Argenica Therapeutics \u83b7\u5f97\u4e2d\u98ce\u836f\u7269 ARG-007 1 \u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u4f26\u7406\u6279\u51c6<\/span><\/a><\/p>\n","protected":false},"author":4,"featured_media":13517,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[888],"yoast_head":"\nArgenica Therapeutics \u83b7\u5f97\u4e2d\u98ce\u836f\u7269 ARG-007 1 \u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u4f26\u7406\u6279\u51c6<\/title>\n<meta name=\"description\" content=\"\u603b\u90e8\u4f4d\u4e8e\u73c0\u65af\u7684\u751f\u7269\u6280\u672f\u516c\u53f8 Argenica Therapeutics (ASX: AGN) \u5df2\u83b7\u5f97\u4f26\u7406\u6279\u51c6\uff0c\u53ef\u4ee5\u5728\u5065\u5eb7\u53c2\u4e0e\u8005\u4e2d\u5f00\u59cb\u5148\u5bfc\u836f\u7269 ARG-007 \u7684\u5173\u952e 1 \u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Argenica Therapeutics \u83b7\u5f97\u4e2d\u98ce\u836f\u7269 ARG-007 1 \u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u4f26\u7406\u6279\u51c6\" \/>\n<meta property=\"og:description\" content=\"\u603b\u90e8\u4f4d\u4e8e\u73c0\u65af\u7684\u751f\u7269\u6280\u672f\u516c\u53f8 Argenica Therapeutics (ASX: AGN) \u5df2\u83b7\u5f97\u4f26\u7406\u6279\u51c6\uff0c\u53ef\u4ee5\u5728\u5065\u5eb7\u53c2\u4e0e\u8005\u4e2d\u5f00\u59cb\u5148\u5bfc\u836f\u7269 ARG-007 \u7684\u5173\u952e 1 \u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/argenica-therapeutics-ethics-approval-phase-1-clinical-trial-stroke-drug-arg-007\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-07T02:02:44+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T17:55:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Argenica-Therapeutics-ASX-AGN-Phase-1-clinical-trial-stroke-roadmap.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Imelda Cotton\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Imelda Cotton\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/argenica-therapeutics-ethics-approval-phase-1-clinical-trial-stroke-drug-arg-007\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/argenica-therapeutics-ethics-approval-phase-1-clinical-trial-stroke-drug-arg-007\/\",\"name\":\"Argenica Therapeutics \u83b7\u5f97\u4e2d\u98ce\u836f\u7269 ARG-007 1 \u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u4f26\u7406\u6279\u51c6\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2022-09-07T02:02:44+00:00\",\"dateModified\":\"2023-08-29T17:55:30+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e\"},\"description\":\"\u603b\u90e8\u4f4d\u4e8e\u73c0\u65af\u7684\u751f\u7269\u6280\u672f\u516c\u53f8 Argenica Therapeutics (ASX: AGN) \u5df2\u83b7\u5f97\u4f26\u7406\u6279\u51c6\uff0c\u53ef\u4ee5\u5728\u5065\u5eb7\u53c2\u4e0e\u8005\u4e2d\u5f00\u59cb\u5148\u5bfc\u836f\u7269 ARG-007 \u7684\u5173\u952e 1 \u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/argenica-therapeutics-ethics-approval-phase-1-clinical-trial-stroke-drug-arg-007\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/argenica-therapeutics-ethics-approval-phase-1-clinical-trial-stroke-drug-arg-007\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/argenica-therapeutics-ethics-approval-phase-1-clinical-trial-stroke-drug-arg-007\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Argenica Therapeutics \u83b7\u5f97\u4e2d\u98ce\u836f\u7269 ARG-007 1 \u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u4f26\u7406\u6279\u51c6\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e\",\"name\":\"Imelda Cotton\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g\",\"caption\":\"Imelda Cotton\"},\"description\":\"Imelda Cotton has over 20 years experience as a journalist and communications professional. She has spent the bulk of her career in the resources sector, having also worked directly with oil and gas majors and as a journalist covering a vast array of ASX listed companies within the resources, energy, science and health sectors.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=4\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Argenica Therapeutics \u83b7\u5f97\u4e2d\u98ce\u836f\u7269 ARG-007 1 \u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u4f26\u7406\u6279\u51c6","description":"\u603b\u90e8\u4f4d\u4e8e\u73c0\u65af\u7684\u751f\u7269\u6280\u672f\u516c\u53f8 Argenica Therapeutics (ASX: AGN) \u5df2\u83b7\u5f97\u4f26\u7406\u6279\u51c6\uff0c\u53ef\u4ee5\u5728\u5065\u5eb7\u53c2\u4e0e\u8005\u4e2d\u5f00\u59cb\u5148\u5bfc\u836f\u7269 ARG-007 \u7684\u5173\u952e 1 \u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Argenica Therapeutics \u83b7\u5f97\u4e2d\u98ce\u836f\u7269 ARG-007 1 \u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u4f26\u7406\u6279\u51c6","og_description":"\u603b\u90e8\u4f4d\u4e8e\u73c0\u65af\u7684\u751f\u7269\u6280\u672f\u516c\u53f8 Argenica Therapeutics (ASX: AGN) \u5df2\u83b7\u5f97\u4f26\u7406\u6279\u51c6\uff0c\u53ef\u4ee5\u5728\u5065\u5eb7\u53c2\u4e0e\u8005\u4e2d\u5f00\u59cb\u5148\u5bfc\u836f\u7269 ARG-007 \u7684\u5173\u952e 1 \u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/argenica-therapeutics-ethics-approval-phase-1-clinical-trial-stroke-drug-arg-007\/","og_site_name":"smallcapsCN","article_published_time":"2022-09-07T02:02:44+00:00","article_modified_time":"2023-08-29T17:55:30+00:00","og_image":[{"width":640,"height":400,"url":"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Argenica-Therapeutics-ASX-AGN-Phase-1-clinical-trial-stroke-roadmap.jpg","type":"image\/jpeg"}],"author":"Imelda Cotton","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Imelda Cotton"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/argenica-therapeutics-ethics-approval-phase-1-clinical-trial-stroke-drug-arg-007\/","url":"https:\/\/smallcapscn.x5view.co\/argenica-therapeutics-ethics-approval-phase-1-clinical-trial-stroke-drug-arg-007\/","name":"Argenica Therapeutics \u83b7\u5f97\u4e2d\u98ce\u836f\u7269 ARG-007 1 \u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u4f26\u7406\u6279\u51c6","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2022-09-07T02:02:44+00:00","dateModified":"2023-08-29T17:55:30+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e"},"description":"\u603b\u90e8\u4f4d\u4e8e\u73c0\u65af\u7684\u751f\u7269\u6280\u672f\u516c\u53f8 Argenica Therapeutics (ASX: AGN) \u5df2\u83b7\u5f97\u4f26\u7406\u6279\u51c6\uff0c\u53ef\u4ee5\u5728\u5065\u5eb7\u53c2\u4e0e\u8005\u4e2d\u5f00\u59cb\u5148\u5bfc\u836f\u7269 ARG-007 \u7684\u5173\u952e 1 \u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/argenica-therapeutics-ethics-approval-phase-1-clinical-trial-stroke-drug-arg-007\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/argenica-therapeutics-ethics-approval-phase-1-clinical-trial-stroke-drug-arg-007\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/argenica-therapeutics-ethics-approval-phase-1-clinical-trial-stroke-drug-arg-007\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"Argenica Therapeutics \u83b7\u5f97\u4e2d\u98ce\u836f\u7269 ARG-007 1 \u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u4f26\u7406\u6279\u51c6"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e","name":"Imelda Cotton","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g","caption":"Imelda Cotton"},"description":"Imelda Cotton has over 20 years experience as a journalist and communications professional. She has spent the bulk of her career in the resources sector, having also worked directly with oil and gas majors and as a journalist covering a vast array of ASX listed companies within the resources, energy, science and health sectors.","url":"https:\/\/smallcapscn.x5view.co\/?author=4"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/5767"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=5767"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/5767\/revisions"}],"predecessor-version":[{"id":15646,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/5767\/revisions\/15646"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/13517"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=5767"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=5767"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=5767"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}